USPTO serial 90501795
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William E. Anderson
William E. Anderson CHRISTENSEN, FONDER, DARDI & HERBERT PLLC11322 86TH AVENUE NORTHMAPLE GROVE, MN 55369United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations in the nature of implantable materials, namely, pliable, synthetic hydrogel for medical and surgical purposes; pharmaceutical preparations in the nature of implantable materials, namely, pliable, synthetic hydrogel for embolization therapy in interventional radiology and oncology; pharmaceutical preparations, namely, differentiated liquid embolics for interventional radiology; embolic agents delivered through a microcatheter under fluoroscopic control; kits that contain precursors that react to form a hydrogel when combined with each other and applicators therefore for use in medical and surgical procedures; system for vascular embolization procedures, namely, a embolization therapy system, featuring hydrogel precursors and applicator; a kit for vascular embolization procedures, featuring hydrogel precursors and applicator | ACTIVE | — |
| 010 | Surgical apparatuses and instruments; embolic device for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; embolic devices in the nature of liquid embolics delivered through microcatheter systems for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, organs and segmental embolizations; in situ polymerizing hydrogel-based medical devices for the treatment of anomalies in the vasculature of the body | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 8, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 1, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 1, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 1, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 3, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 1, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 1, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 30, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 30, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 30, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 1, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |